SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-008190
Filing Date
2019-03-18
Accepted
2019-03-18 14:01:34
Documents
3
Period of Report
2019-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-8k_20190318.htm 8-K 30086
2 EX-99.1 apvo-ex991_40.htm EX-99.1 297360
3 GRAPHIC gxmlldv0trs1000001.jpg GRAPHIC 2623
  Complete submission text file 0001564590-19-008190.txt   332341
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 19687719
SIC: 2834 Pharmaceutical Preparations